Early data presented at ASCO annual meeting 2023 shows encouraging responses to treatment in a very difficult to treat patient population Dr. Anthony Kong (Guy’s and St Thomas’ Hospitals, London), Principal Investigator, presented data from ProcemISA, an ongoing clinical trial in anti-PD1…

STRASBOURG, France, 6 juin 2023 /PRNewswire/ — A l’occasion de VivaTechnology, IMKI, une startup spécialisée dans la conception et le développement d’IA génératives sur mesure, présentera ses solutions dédiées aux industries du Luxe, pour produire des outils puissants d’aide à la…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.